Abstract
Extracorporeal shock wave lithotripsy has become a valuable asset to the urologist and greatly benefits urologic stone patients. Eight years of clinical use have proven its clinical efficacy, with more than 400,000 successfully performed treatments worldwide. In a short period of time, ESWL has completely changed the management of urinary stone disease and has almost entirely supplanted open surgical and most endourologic approaches. It is less expensive than other lithotripsy methods, is noninvasive, and usually causes only minimal postprocedural discomfort. Outpatient treatment or a very short hospital stay is the norm, and most patients resume their normal activities almost immediately.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.